Rare dosage abnormalities flanking the SHOX gene
Background Transcriptional regulation of the SHOX gene is highly complex. Much of our understanding has come from the study of copy number changes of conserved non-coding sequences both upstream and downstream of the gene. Downstream deletions have been frequently reported in patients with Leri–Weill dyschondrosteosis or idiopathic short stature. In contrast, there are only four cases in the literature of upstream deletions that remove regulatory elements. Although duplications flanking the SHOX gene have also been reported, their pathogenicity is more difficult to establish. To further evaluate the role of flanking copy number variants in SHOX-related disorders, we describe nine additional patients from a large SHOX diagnostic cohort. Results The nine cases presented here include five with duplications (two upstream of SHOX and three downstream), one with a downstream triplication and three with upstream deletions. Two of the deletions remove a single conserved non-coding element (CNE-3) while the third does not remove any known regulatory element but is just 4 kb upstream of SHOX, and the deleted region may be important in limb bud development. We also describe six families with novel sequence gains flanking SHOX. Three families had increased dosage of a proposed regulatory element approximately 380 kb downstream of SHOX (X:970,000), including one family with the first ever reported triplication of this region. One family had two in cis downstream duplications co-segregating with LWD, and the two others had a duplication of just the upstream SHOX regulatory element CNE-5. Conclusions This study further extends our knowledge of the range of variants that may potentially cause SHOX-related phenotypes and may aid in determining the clinical significance of similar variants..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The Egyptian journal of medical human genetics - 22(2021), 1 vom: 10. Dez. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bunyan, David J. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Author(s) 2021 |
|---|
| doi: |
10.1186/s43042-021-00209-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR045770158 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR045770158 | ||
| 003 | DE-627 | ||
| 005 | 20230519125622.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211210s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s43042-021-00209-1 |2 doi | |
| 035 | |a (DE-627)SPR045770158 | ||
| 035 | |a (SPR)s43042-021-00209-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |a 570 |q ASE |
| 100 | 1 | |a Bunyan, David J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rare dosage abnormalities flanking the SHOX gene |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2021 | ||
| 520 | |a Background Transcriptional regulation of the SHOX gene is highly complex. Much of our understanding has come from the study of copy number changes of conserved non-coding sequences both upstream and downstream of the gene. Downstream deletions have been frequently reported in patients with Leri–Weill dyschondrosteosis or idiopathic short stature. In contrast, there are only four cases in the literature of upstream deletions that remove regulatory elements. Although duplications flanking the SHOX gene have also been reported, their pathogenicity is more difficult to establish. To further evaluate the role of flanking copy number variants in SHOX-related disorders, we describe nine additional patients from a large SHOX diagnostic cohort. Results The nine cases presented here include five with duplications (two upstream of SHOX and three downstream), one with a downstream triplication and three with upstream deletions. Two of the deletions remove a single conserved non-coding element (CNE-3) while the third does not remove any known regulatory element but is just 4 kb upstream of SHOX, and the deleted region may be important in limb bud development. We also describe six families with novel sequence gains flanking SHOX. Three families had increased dosage of a proposed regulatory element approximately 380 kb downstream of SHOX (X:970,000), including one family with the first ever reported triplication of this region. One family had two in cis downstream duplications co-segregating with LWD, and the two others had a duplication of just the upstream SHOX regulatory element CNE-5. Conclusions This study further extends our knowledge of the range of variants that may potentially cause SHOX-related phenotypes and may aid in determining the clinical significance of similar variants. | ||
| 650 | 4 | |a Regulatory element |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Deletion |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Duplication |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Gevers, Evelien |e verfasserin |4 aut | |
| 700 | 1 | |a Hobbs, James I. |e verfasserin |4 aut | |
| 700 | 1 | |a Duncan-Flavell, Philippa J. |e verfasserin |4 aut | |
| 700 | 1 | |a Howarth, Rachel J. |e verfasserin |4 aut | |
| 700 | 1 | |a Holder-Espinasse, Muriel |e verfasserin |4 aut | |
| 700 | 1 | |a Klee, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Van-Heurk, Roxane |e verfasserin |4 aut | |
| 700 | 1 | |a Lemmens, Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Carminho-Rodrigues, Maria Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Mohamed, Zainaba |e verfasserin |4 aut | |
| 700 | 1 | |a Goturu, Aruna |e verfasserin |4 aut | |
| 700 | 1 | |a Hughes, Claire R. |e verfasserin |4 aut | |
| 700 | 1 | |a Ajzensztejn, Michal |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, N. Simon |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Egyptian journal of medical human genetics |d Cairo : Egyptian Society of Medical Human Genetics, Medical Genetics Center, AinShams University, 2000 |g 22(2021), 1 vom: 10. Dez. |w (DE-627)SPR038848686 |w (DE-600)2515357-2 |x 2090-2441 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:1 |g day:10 |g month:12 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s43042-021-00209-1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 1 |b 10 |c 12 | ||